Equity Research

Global toy-and-game maker (est. 1923) whose story splits in two: a secularly pressured, China-sourcing-exposed traditional-toy Consumer Products segment, and Wizards of the Coast & Digital Gaming — the high-margin crown jewel built on Magic: The Gathering and Dungeons & Dragons that is driving the growth and margin mix higher. FY2025 GAAP shows a net loss on a $1.02B non-cash Consumer Products goodwill impairment (tariff-driven margin reassessment), but adjusted diluted EPS hit a record $5.54 and free cash flow reached a 5-year high of $829.9M — the write-down never touched cash. The "Playing to Win" cost program and post-eOne deleveraging support the turnaround. Valued on adjusted earnings (GAAP is N/M): 14.7x trailing / 13.6x FY2026E, EV/EBITDA ~10.7x, 3.4% dividend yield. Consensus 1Y PT $105.53 (~+29%). Q2 earnings land Jul 21, 2026 — an immediate catalyst.

Dominant accelerated-computing / AI platform — data-center GPUs (Blackwell ramp), the CUDA software moat, and Mellanox networking — now a ~$5.1T mega-cap. FY2026 (ended Jan 2026) revenue scaled at extraordinary margins on a near-net-cash balance sheet. Trades at 43x trailing / ~26x FY2027E earnings, but PEG is ~0.4 on ~60%+ EPS growth, so the forward multiple is undemanding for the growth. Near-unanimous Street Buy (~88%); 1Y consensus PT $322.63 (~+53% upside). Risks: China export controls, hyperscaler-capex digestion, custom-ASIC/AMD competition, and the absolute valuation.

Small-cap, vertically integrated coffee/tea/beverage manufacturer (roasting, extracts, ready-to-drink, single-serve, plus green-coffee sourcing) — not to be confused with West Pharmaceutical (WST) or Smurfit WestRock. The entire thesis is the large Conway, Arkansas facility ramping after a capex-heavy, cost-overrun buildout to drive a revenue/margin inflection. Still unprofitable (EPS −$0.94, P/E N/M) and cash-burning, carrying buildout debt, with commodity coffee-cost and dilution risk — a speculative turnaround. Valued on EV/Sales (1.18x) since earnings are negative; EV/EBITDA 72.6x on thin FY2025 EBITDA. Coverage is thin (3 boutique analysts maintain Buy on the ramp), but the stock has rallied to ~$9.19, above the ~$7.50 average price target. Execution-dependent.

Asset-light IP / patent-licensing pure-play (just ~150 employees) spun out of the 2022 Xperi separation, collecting recurring royalties across two families: media/entertainment (MVPDs, OTT/streaming, consumer electronics) and semiconductor — notably hybrid bonding for advanced packaging / 3D stacking, the AI-adjacent growth vector. Very high licensing margins, but revenue is lumpy on renewals and litigation, and it carries term-loan debt from the split (net debt ~$363M) so deleveraging is part of the thesis. Trades at 16.1x EV/EBITDA / 32.1x earnings with a 4.3% FCF yield. Coverage is thin (4 boutique analysts, unanimous Buy); 1Y PT $34.50 (~9% upside). Risks: pay-TV decline, renewal/customer concentration, patent-runway, and litigation outcomes.

Micro-cap (~$505M, just 41 employees) spintronics specialist — magnetic sensors and couplers for factory automation, medical, and industrial IoT, plus MRAM licensing IP. Extremely high margins, debt-free and cash-rich, and run largely as a fixed-dividend income vehicle ($4.00/yr, 3.83% yield). The catch: revenue is lumpy/mature and FCF (~$14.5M) covers only ~75% of the ~$19.3M dividend, with the balance funded from the investment portfolio. No active analyst coverage — verdict (HOLD) is derived from valuation, yield, and balance sheet. Trades at 33.3x earnings, the richest of its 5-year history. Risks: customer concentration, micro-cap liquidity, dividend coverage.

The aerospace pure-play left after GE's three-way split (GE HealthCare spun Jan 2023, GE Vernova Apr 2024) — jet engines for commercial and defense, with a CFM/LEAP installed base that drives a high-margin services aftermarket annuity. The thesis is the LEAP shop-visit/spare-parts ramp plus Culp's lean (FLIGHT DECK) margin expansion and strong FCF. FY2025 is the first full standalone year; pre-2024 statements reflect the old conglomerate scope (annotated in the report). Premium multiple — 40.6x trailing P/E, 29.3x EV/EBITDA. Consensus BUY; 1Y PT $374.50 (~13% upside). Risks: air-travel cyclicality, LEAP durability/shop-visit timing, and supply chain.

~$1T mega-cap pharma whose thesis is the incretin / GLP-1 franchise — tirzepatide (Mounjaro for type-2 diabetes, Zepbound for obesity) — driving a revenue ramp that justifies a premium multiple. FY2025 EPS $22.95 (47.4x trailing) compresses to 29.7x on FY2026E $36.57 as volume and manufacturing capacity scale. Pipeline optionality in the oral GLP-1 orforglipron and donanemab (Kisunla, Alzheimer's); the key contest is vs Novo Nordisk (Wegovy/Ozempic). Consensus BUY; 1Y PT $1,291.90 (~19% upside). Bear case is multiple compression, not market beta (β≈0.48).

One of the big-3 wafer-fab-equipment makers, leading in etch and deposition (ALD/CVD/ECD) alongside Applied Materials and Tokyo Electron. NAND-heavy mix makes the memory-capex recovery a key swing factor, with HBM/advanced packaging and gate-all-around logic as added drivers. Post-10:1 split (Oct 2025): ~$340, 1.29B shares, FY2025 EPS $4.15. Trades at a rich 82x trailing / 66.9x EV/EBITDA — a de-rating depends on the NAND/HBM earnings recovery materializing. Consensus BUY; 1Y PT $396.50 (~17% upside). Key risk: China export-control exposure and WFE cyclicality.

The lowest-cost, highest-margin copper major (FY2025 EBITDA margin ~60%, ROE 39%, net debt/EBITDA 0.39x), with 50+ year reserve life across Peru and Mexico and ~88% control by Grupo México. The quality is real and earns a structural peer premium — but at ~21x EV/EBITDA (vs Teck ~8.6x) the multiple sits at the top of its own historical range, requiring record copper AND peak multiples at once. Sell-side skews negative; 1Y consensus PT $143.54 implies ~27% downside. Risks: Tía María permitting, Mexican royalty/politics, controlled-company governance, and asymmetric downside on any copper correction.

Critical digital-infrastructure provider — data-center power management, thermal/cooling, and integrated racks (Liebert, NetSure, Geist brands) — and a direct beneficiary of the AI data-center buildout. FY2025 revenue scaling on hyperscaler capex; trailing P/E 92.6x and EV/EBITDA 55.8x price in sustained growth, compressing to ~36x on FY2027E EPS of $8.75. Near-unanimous Street BUY (12 of 13 ratings constructive); 1Y consensus PT $408.57 implies ~21% upside. High-beta (β≈2.1) cyclical-growth name levered to the data-center capex cycle.

Permian Basin (Midland + Delaware) oil & gas E&P, transformed by the ~$26B Endeavor Energy acquisition (2024) and Double Eagle (2025) that roughly doubled its scale to ~$15B revenue and $8.8B operating cash flow. FY2025 free cash flow ~$5.2B (≈9.7% yield) on normalized capex; net debt ~$14.4B post-deal, returned via a base-plus-variable dividend. Reported beta of 0.44 badly understates WTI commodity sensitivity — the real swing factor. Consensus BUY; 1Y PT $232.38 (~21% upside).

Maker of containment and delivery systems for injectable drugs — elastomer stoppers/seals, Crystal Zenith vials/syringes, and self-injection devices (Proprietary Products) plus a Contract-Manufactured segment. A high-quality razor/razorblade compounder whose stock has re-rated +57% off its 52-week low to near its high. Trades at 47.5x trailing / 33.7x FY2027E earnings — a premium multiple with limited margin of safety. Consensus HOLD; 1Y PT $315.06 sits ~2% below the current price. Swing factors: high-value-product volume recovery, post-COVID vial destocking, and GLP-1 device demand.

Precious-metals streaming company (not a miner): pays mining partners upfront for the right to buy a fixed % of future gold/silver/cobalt output at a low fixed per-ounce cost. ~44 employees, debt-free with net cash, extreme cash margins, and direct leverage to the gold/silver price deck with capped cost inflation. Record Q1 2026; the BHP Antamina silver stream is a near-term catalyst. P/NAV (P/B ~6.9x) and price-to-operating-cash-flow are the primary lenses, not P/E (~40x). Consensus BUY; 1Y PT $142.42 (~7% upside), with recent Street targets up to $180.

Post-coal copper-focused diversified miner (NYSE: TECK, TSX: TECK.B), Vancouver-based. Sold steelmaking coal to Glencore in 2024; now pure copper + zinc. Flagship QB2 mine in Chile ramping toward 500K+ tonne copper capacity. FY2025 revenue C$10.75B, EBITDA C$4.37B, EV/EBITDA 8.6x. Q1 2026 EPS +207% on record copper sales. Copper at record highs on AI/electrification demand. Consensus skews HOLD — all PT averages below current $66.16. FCF negative in FY2025 (QB2 capex); FCF inflection thesis for 2026–27. Reports in CAD; NYSE price in USD.

Integrated aluminum major spanning bauxite mining, alumina refining, and aluminum smelting — a deeply cyclical, commodity-price-driven producer. FY2025 revenue $12.7B, EBITDA $1.86B, FCF $567M. Stock jumped ~7.7% on the session on an LME aluminum / tariff catalyst, sitting near its 52-week high. UBS upgraded to Buy (May 22) and consensus skews bullish (avg PT $74.33). A single-point FCF model is weak for a deep cyclical, so mid-cycle EV/EBITDA is the key cross-check. Key risks: LME aluminum/alumina prices, energy input costs, and Section 232 tariff policy.

HPC/AI data-center developer and operator that pivoted from crypto-mining hosting. FY2025 (May year-end) revenue $215M with deeply negative FCF (-$797M) as it builds out AI capacity — the thesis rests on a reported ~$31B contracted backlog, not current financials. Unanimous Street BUY (avg PT ~$64). Reported beta of 5.7 is unusable for cost of equity (a ~2.0 cap is more realistic), and valuation is a terminal-value/scenario exercise with a very wide bull-bear spread. Highly speculative AI-infrastructure name; valuation hinges entirely on executing the backlog.

Global electronic-components and enterprise-computing distributor — a high-revenue, very-low-margin intermediary model (FY2025 revenue $30.9B). FY2025 FCF was -$114M, but that's a working-capital artifact of the cycle recovery (AR rebuild); normalized FCF runs $400-600M/yr. Trades near a 52-week high at ~10.9x FY26E EPS on cycle-normalization optimism (consensus FY26E EPS +83%). Mixed Street view (avg PT $208, just below price); William Austen is interim CEO. Capital return is via buybacks ($1B authorization), no dividend. Key risk: the semiconductor inventory/destocking cycle.

KKR-backed, acquisition-driven US oil & gas E&P across the Eagle Ford, Rockies, Permian, and Mid-Continent. FY2025 inflected to strongly positive free cash flow (+$729M, a ~17% yield) and trades below book (0.84x) at ~6x EV/EBITDA and ~5.7x forward earnings. Overweight/Buy consensus, with a recent Street target as high as $20. The catch is leverage — net debt $5.7B, ~3.4x net debt/EBITDA — plus full commodity-price exposure and noisy GAAP earnings. Modestly undervalued on mid-cycle assumptions, with a conservative organic-growth taper and a sector-adjusted beta.

US pure-play semiconductor foundry (Trusted/rad-hard, aerospace & defense, advanced-technology services + wafer manufacturing) with CHIPS-Act / onshoring tailwinds. The dominant consideration is the pending IonQ acquisition — stockholders approved it May 8, 2026 — making this effectively a merger-arb situation; TD Cowen, Piper, and Needham all downgraded to Hold/Neutral on the deal. FY2025 revenue $442M, FCF -$53M; the stock has run ~355% off its low on deal momentum. A standalone fair value (~$14-20) sits well below market — the gap is the merger premium. Analyst coverage is thin.

Greek-managed crude-oil and petroleum-product TANKER shipping company (note: not Tenneco) — owns a fleet of crude, product, LNG, and shuttle tankers on mixed charters. Deeply cyclical, asset-heavy, and trading at ~0.70x book, so P/NAV is the primary valuation lens. Coverage is thin — a lone Jefferies Hold ($50 PT) — but Q1 2026 net income of $89M (+160% YoY) suggests upside to that estimate. Key risks: tanker charter-rate cyclicality, lumpy fleet capex, and a small, thinly-traded float.

Permian-focused integrated E&P with Berkshire Hathaway as anchor shareholder (~28% economic stake). Q1 2026 EPS $1.06 beat consensus by 63% on production strength, but stock down -7% today on Iran peace deal speculation. FY2025 FCF $4.1B, dividend yield 4.0%, EV/EBITDA 5.5x. Long-term debt down to $20.4B (lowest since 2016) — deleveraging story with years of runway. Berkshire warrants ($59 strike on 84M shares) cap upside near current price. CEO Hollub transitioning operational responsibility to Richard Jackson.

Largest financial holding company in South Korea (~₩758T total assets, ~$549B USD). Trades at 0.76x book value with 9.5% ROE and 2.9% dividend yield — Korean Value-Up reform agenda is the rerating catalyst markets are watching. Q1 2026 EPS beat by 8% on net interest margin expansion and best-in-industry 39.3% cost-to-income ratio. Capital returns scaling from ₩982B (FY21) to ₩2.31T (FY24). KB ADR is 1:1 with Korean ordinary; reported in KRW (FX 1,380 KRW/USD). P/B vs target ROE is the primary valuation framework for a bank.

Sydney-based vertically integrated data center operator pivoting from Bitcoin self-mining to AI cloud infrastructure ("neocloud"). FY2025 (June): revenue $501M (+168%), first GAAP profitable year — but FCF deeply negative -$1.13B as capex spiked to 274% of revenue funding the AI buildout. Sweetwater 1 (1.4 GW Texas) just energized May 1; Mirantis acquisition (May 5) adds Kubernetes orchestration. Management targets $3.4B AI ARR by end-2026. Beta 4.18 (extreme volatility); both co-CEOs sold $33M each at $33.13 in Sept 2025. Stock has 9.6x'd from $6.36 low.

World's largest Western-aligned uranium producer plus 49% Westinghouse Electric stake (with Brookfield). FY2025 revenue CAD 3.48B (+11%) with FCF CAD 1.02B and net cash balance sheet (-CAD 92M net debt). Q1 2026 EPS beat by 17%; Scotiabank just raised PT to $175 (May 6) citing nuclear renaissance acceleration. 78GW of nuclear under construction across 15 countries; long-term uranium contract pricing now exceeds spot. Stock has rerated to 92.8x P/E and 7.9x P/B — pricing in flawless execution; 1Y consensus PT of $115 is below current price. Reports in CAD.

World's largest semiconductor packaging and test (OSAT) provider — the only credible merchant alternative to TSMC's CoWoS for AI advanced packaging. FY2025 revenue $20.9B (+6.8%), but capex spiked to 25% of revenue ($5.3B) and FCF turned negative -$645M as the company funds the AI/HBM advanced-packaging buildout. Management guides FY2026 leading-edge advanced packaging revenue to $3.5B+ (+10% YoY) and LEAP test services to nearly double. Stock has tripled in 12 months to 98% of 52-week range; FY2026E P/E compresses to 15.2x on consensus +78% EPS growth. Heavy insider selling — director sold 11 times in 21 days at the all-time high.

Dominant supplier of custom AI accelerators (XPUs) to Google, Meta, and ByteDance, plus the consolidated owner of VMware after the $69B 2023 acquisition. FY2025 revenue $63.9B (+24%), FCF $26.9B (42% margin). Consensus models $103.6B FY2026 revenue (+62%) on Hock Tan's $100B custom AI silicon framing. Stock trades 88% of 52-week range at $400 after Tuesday's 4.4% AI capex selloff; 1Y consensus PT $419.79 implies just 5% upside. Heavy insider selling at recent highs (co-founder Samueli sold ~$230M on Mar 25).

Pure-play Floating LNG (FLNG) operator with two units in operation (Hilli, Gimi) and Mark II under construction at Seatrium for 2027–2028 delivery. FY2025 revenue jumped +51% to $394M as the Gimi project ramped. Strategic alternatives review with Goldman Sachs creates corporate-action optionality. Analyst consensus models EBITDA more than doubling to $405M by FY2028. Dividend yield of 7.6% pays investors to wait through the construction window.

Canada's largest integrated energy company with 40+ years of long-life oil sands reserves, four refineries, and the Petro-Canada retail network. FY2025 revenue $48.9B CAD, EBITDA $16.2B CAD, FCF $6.9B CAD. Returned $5.95B CAD (~12% of market cap) via buybacks and dividends. EV/EBITDA of 5.5x screens cheap vs Canadian and US integrated peers. JPMorgan upgraded to Overweight Jan 2026; consensus PT of $72 implies 12.5% upside.

Diversified copper miner with operations in Manitoba, Saskatchewan, and Cusco (Peru), plus development assets at Copper World (AZ), Mason (NV), and the recently acquired Cactus project. FY2025 was an inflection year — EPS jumped from $0.20 to $1.46 (+651%) as copper broke out and operating leverage flowed through. Net debt/EBITDA fell to 0.51x from 4.3x in FY2021. Beta of 2.15 makes the stock a leveraged play on copper demand from data centers and EVs.

Pure-play HDD manufacturer following the Feb 2025 SanDisk spinoff. FY2025 revenue of $9.52B (+51% YoY) marks the first clean year of the standalone HDD company. Stock surged 10x from its 52-week low to $350 — well above the consensus price target of $303. AI-driven nearline storage demand is the core bull case; valuation at 67x trailing P/E and 12.5x revenue prices in near-perfect execution.

$128B infrastructure and PC giant riding the AI server buildout. ISG AI server demand drove 18.8% revenue growth to $113.5B in FY2026, with FCF of $8.6B and EPS of $8.68 (+36% YoY). Stock surged to $189.79 on Nvidia acquisition rumors (denied); consensus target $161.75 implies ~15% downside. Aggressive buyback program reduced shares 14% over 5 years.

$53B fabless semiconductor company at the center of the custom AI silicon and co-packaged optics megatrend. AI revenue ramping from $1.5B (FY2025) toward $8B by FY2028 via Amazon Trainium and Google XPU programs. PAM4 DSPs are mission-critical infrastructure in every next-gen AI data center switch. Stock down 47% from highs — analysts see 66% upside to $103 consensus target.

$25.8B fabless semiconductor company competing in AI accelerators, server CPUs, and adaptive computing. Data Center GPU ramp via MI300X/MI350 positions AMD as the primary NVIDIA alternative. EPYC server CPUs hold 30%+ market share vs. Intel. GAAP earnings depressed by $4B/yr Xilinx amortization; non-GAAP EPS $3.31 growing 58% in FY2026E.

$403B revenue mega-cap dominating search, cloud, and YouTube. FY2025 net income $132B with 33% net margins. CapEx surged to $91B (22.7% of revenue) for AI infrastructure buildout, compressing FCF yield to 1.9% despite accelerating OCF.

Leading DRAM and NAND manufacturer riding the HBM supercycle. FY2025 revenue $37.4B (+49% YoY) with massive CapEx intensity (42% of revenue) for HBM3E buildout. FCF compressed to $1.7B despite $17.5B OCF. Analyst consensus BUY with QTR PT of $456.

Premier analog and mixed-signal semiconductor franchise with 125,000+ SKUs across industrial, automotive, communications, and consumer. FY2025 revenue $11.0B in cyclical recovery with 44% OCF margins and $4.3B FCF. Low CapEx intensity (4.8% of revenue) drives superior FCF conversion.

World's largest semiconductor equipment company. Dominant positions in CVD, PVD, ALD, CMP, and ion implantation covering ~22-25% of global WFE spend. Gate-all-around transition at TSMC/Samsung/Intel structurally increases tool intensity per wafer. FY2025 revenue $28.4B, AGS services business growing.

World's largest contract chipmaker with a monopoly on leading-edge nodes (2nm, 3nm). Revenue up 33% in FY2025 with 60% gross margins as AI infrastructure demand drives capacity sold out through 2027. Net cash position of $52B.

Premier pure-play on the AI-driven electricity supercycle. $150B+ backlog across gas turbines, wind, and grid electrification. Debt-free with $8.8B cash and $3.7B FCF. Near all-time highs as institutional money rotates from AI chips to power infrastructure.

Financial platform powering QuickBooks, TurboTax, Credit Karma, and ProConnect for 100M+ customers. Down 55% from highs on SaaSpocalypse fears, trading at 15.1x forward earnings with 80%+ gross margins and $6.1B FCF.

Offshore contract drilling leader with a fleet of ultra-deepwater and harsh environment floaters. Operationally improving with $626M FCF in FY2025, aggressive deleveraging, and $1B in new backlog.